Pfizer's long-acting GLP-1 weight loss candidate could set the stage for a stock rally.
The stock has been fairly stable over the past year.
Pfizer Inc. (NYSE:PFE) is included among the Dividend Champions, Contenders, and Challengers List: 15 Highest Yielding Stocks ...
For income investors, there are numerous dividend stocks with strong records, stability and growth potential that can generate wealth for you in the long term.
Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should significantly boost the drugmaker's bottom line. Pfizer's ...
Pfizer may look cheap with a ~7% yield, but tight free cash flow, patent cliffs, and limited growth raise downside risk. Read the full analysis before buying.
Which of the highest-yielding healthcare stocks are value traps or golden opportunities?
Pfizer's dividend payout ratio is high, but the company is generated enough free cash flow to cover its dividend. Management remains committed to the dividend program despite Pfizer facing a patent ...
What does a successful retirement look like? If it means financial security through steady income sources, then you can get ...
A high-yielding payout hasn't been enough reason for investors to buy Pfizer's stock. The pharmaceutical giant's valuation has been cut in half in just three years. Investors appear to be worried ...
These three cheap dividend stocks have a yield higher than 5% and a strong record of dividend increases. Build a passive income portfolio with these stocks and you won’t be disappointed. Follow 24/7 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results